Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile



Court Orders Johnson & Johnson To Pay $1.2 Billion In Deceptive Marketing Case

Johnson & Johnson and a subsidiary have to pay for the way it marketed antipsychotic drug Risperdal, neglecting to mention its side effects while claiming it was safer and worked better than the competition. In Arkansas, one of 11 states in which J&J has faced legal battles over the drug, a judge ordered the company to pay $1.2 billion to make up for its alleged sins. CNNMoney reports the companies' allegedly deceptive practices caused government-subsidized healthcare services to pay for the drug, which is believed to put patients at risk of diabetes and neurological problems.
read more

share

Copyright © 2011 Regator, LLC